Published in Obesity and Diabetes Week, April 3rd, 2006
V.A. Fonseca and colleagues at Tulane University conducted a randomized study including "57 patients with type 2 diabetes mellitus (T2DM) to either (1) continuous subcutaneous basal Lispro insulin at a single rate using an insulin pump (basal insulin) or (2) basal insulin and oral pioglitazone 10 mg...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.